Silk Capital

Silk Capital, operating under the name Silk Bridge Partners, focuses on strategic advisory and investment services, particularly in the fast-growing markets of ASEAN-South Asia. Their philosophy emphasizes value creation through partnerships, working closely with management teams to build sustainable, high-performing businesses. Silk Capital invests in a variety of sectors, providing both short-term and long-term financing, growth capital, strategic planning, and assistance with IPOs or M&A activities. Silk Technologies, Ltd., a notable portfolio company, specializes in developing silk-derived protein products for ophthalmic applications, including treatments for dry eye disease and ocular inflammation. This investment highlights Silk Capital's interest in innovative biotech solutions. Their offices are strategically located in Singapore, Delhi, Beijing, and Bangalore, enabling them to maintain strong geographical linkages and leverage their deep relationships in key markets like China, South Asia, Southeast Asia, and the Middle East.